» Articles » PMID: 28838543

A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease

Overview
Publisher Elsevier
Date 2017 Aug 26
PMID 28838543
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (MiRNAs) are a class of endogenously encoded ~22 nucleotide, noncoding, single-stranded RNAs that contribute to development, body planning, stem cell differentiation, and tissue identity through posttranscriptional regulation and degradation of transcripts. Given their importance, it is predictable that dysregulation of MiRNAs, which target a wide variety of transcripts, can result in malignant transformation. In this review, we explore the discovery of MiRNAs, their mechanism of action, and the tools that aid in their discovery and study. Strikingly, many of the studies that have expanded our understanding of the contributions of MiRNAs to normal physiology and in the development of diseases have come from studies in the hematopoietic system and hematologic malignancies, with some of the earliest identified functions for mammalian MiRNAs coming from observations made in leukemias. So, with a special focus on the hematologic system, we will discuss how MiRNAs contribute to differentiation of stem cells and how dysregulation of MiRNAs contributes to the development of malignancy, by providing examples of specific MiRNAs that function as oncogenes or tumor suppressors, as well as of defects in MiRNA processing. Finally, we will discuss the promise of MiRNA-based therapeutics and challenges for the future study of disease-causing MiRNAs.

Citing Articles

Unraveling the microRNAs Involved in Fasciolosis: Master Regulators of the Host-Parasite Crosstalk.

Barrero-Torres D, Herrera-Torres G, Perez J, Martinez-Moreno A, Martinez-Moreno F, Flores-Velazquez L Int J Mol Sci. 2025; 26(1.

PMID: 39796061 PMC: 11719827. DOI: 10.3390/ijms26010204.


Progress in Wound-Healing Products Based on Natural Compounds, Stem Cells, and MicroRNA-Based Biopolymers in the European, USA, and Asian Markets: Opportunities, Barriers, and Regulatory Issues.

Srivastava G, Martinez-Rodriguez S, Fadilah N, Looi Qi Hao D, Markey G, Shukla P Polymers (Basel). 2024; 16(9).

PMID: 38732749 PMC: 11085499. DOI: 10.3390/polym16091280.


MiR-339-5p Inhibits Ferroptosis by Promoting Autophagic Degradation of FTH1 Through Targeting ATG7 in Liver Cancer Cells.

Cao F, Hao W, Liang W, Zeng H, Zheng J Clin Med Insights Oncol. 2024; 18:11795549241244783.

PMID: 38628842 PMC: 11020741. DOI: 10.1177/11795549241244783.


B7-H3 in acute myeloid leukemia: From prognostic biomarker to immunotherapeutic target.

Tan X, Zhao X Chin Med J (Engl). 2024; 137(21):2540-2551.

PMID: 38595093 PMC: 11556994. DOI: 10.1097/CM9.0000000000003099.


MHESMMR: a multilevel model for predicting the regulation of miRNAs expression by small molecules.

Guan Y, Yu C, Li L, You Z, Wei M, Wang X BMC Bioinformatics. 2024; 25(1):6.

PMID: 38166644 PMC: 10763044. DOI: 10.1186/s12859-023-05629-x.


References
1.
Garzon R, Garofalo M, Martelli M, Briesewitz R, Wang L, Fernandez-Cymering C . Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A. 2008; 105(10):3945-50. PMC: 2268779. DOI: 10.1073/pnas.0800135105. View

2.
McPherson J, Marra M, Hillier L, Waterston R, Chinwalla A, Wallis J . A physical map of the human genome. Nature. 2001; 409(6822):934-41. DOI: 10.1038/35057157. View

3.
Visone R, Rassenti L, Veronese A, Taccioli C, Costinean S, Aguda B . Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Blood. 2009; 114(18):3872-9. PMC: 2773482. DOI: 10.1182/blood-2009-06-229211. View

4.
Bousquet M, Harris M, Zhou B, Lodish H . MicroRNA miR-125b causes leukemia. Proc Natl Acad Sci U S A. 2010; 107(50):21558-63. PMC: 3003065. DOI: 10.1073/pnas.1016611107. View

5.
Helwak A, Kudla G, Dudnakova T, Tollervey D . Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell. 2013; 153(3):654-65. PMC: 3650559. DOI: 10.1016/j.cell.2013.03.043. View